Form 8.3 - NortonLifeLock Inc.

RNS Number : 1019X
Barclays PLC
24 August 2022
 

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR

MORE

Rule 8.3 of the Takeover Code (the "Code")

1.

KEY INFORMATION

(a)

Full name of discloser:


Barclays PLC.

(b)

Owner or controller of interest and short



positions disclosed, if different from 1(a):

(c)

Name of offeror/offeree in relation to whose

NORTONLIFELOCK INC


relevant securities this form relates:

(d)

If an exempt fund manager connected with an



offeror/offeree, state this and specify identity of


offeror/offeree:

(e)

Date position held/dealing undertaken:

23 Aug 2022

(f)

In addition to the company in 1(c) above, is the discloser making

YES:




disclosures in respect of any other party to the offer?

AVAST PLC


2.

POSITIONS OF THE PERSON MAKING THE DISCLOSURE

(a)

Interests and short positions in the relevant securities of the offeror or offeree



to which the disclosure relates following the dealing(if any)


Class of relevant security:

USD 0.01 common


Interests

Short Positions


Number

(%)

Number

(%)

(1)

Relevant securities owned






and/or controlled:



1,280,173

0.22%

1,451,276

0.25%

(2)

Cash-settled derivatives:






and/or controlled:



1,727,373

0.30%

3,757,122

0.66%

(3)

Stock-settled derivatives (including options)






and agreements to purchase/sell:



17,100

0.00%

17,100

0.00%










TOTAL:



3,024,646

0.53%

5,225,498

0.91%

(b)

Rights to subscribe for new securities (including directors and other executive



options)







Class of relevant security in relation to





which subscription right exists





Details, including nature of the rights





concerned and relevant percentages:





3.

DEALINGS (IF ANY) BY THE EXEMPT PRINCIPAL TRADER

(a)

Purchases and sales






Class of relevant

Purchase/sale

Number of

Price per unit

security


securities


USD 0.01 common

Purchase

40

23.3000  USD

USD 0.01 common

Purchase

102

23.2550  USD

USD 0.01 common

Purchase

295

23.3031  USD

USD 0.01 common

Purchase

346

23.3100  USD

USD 0.01 common

Purchase

357

23.3090  USD

USD 0.01 common

Purchase

401

23.2821  USD

USD 0.01 common

Purchase

403

23.2800  USD

USD 0.01 common

Purchase

464

23.2486  USD

USD 0.01 common

Purchase

506

23.2911  USD

USD 0.01 common

Purchase

600

23.3166  USD

USD 0.01 common

Purchase

600

23.2600  USD

USD 0.01 common

Purchase

667

23.2682  USD

USD 0.01 common

Purchase

683

23.2857  USD

USD 0.01 common

Purchase

771

23.2949  USD

USD 0.01 common

Purchase

926

23.2961  USD

USD 0.01 common

Purchase

955

23.2962  USD

USD 0.01 common

Purchase

1,236

23.2982  USD

USD 0.01 common

Purchase

1,352

23.2937  USD

USD 0.01 common

Purchase

2,679

23.3542  USD

USD 0.01 common

Purchase

3,000

23.2150  USD

USD 0.01 common

Purchase

3,440

23.2201  USD

USD 0.01 common

Purchase

4,353

23.2415  USD

USD 0.01 common

Purchase

6,021

23.2867  USD

USD 0.01 common

Purchase

7,112

23.2875  USD

USD 0.01 common

Purchase

8,658

23.2779  USD

USD 0.01 common

Purchase

10,630

23.2630  USD

USD 0.01 common

Purchase

12,500

23.2892  USD

USD 0.01 common

Purchase

13,070

23.2914  USD

USD 0.01 common

Purchase

31,902

23.2200  USD

USD 0.01 common

Purchase

66,133

23.3114  USD

USD 0.01 common

Purchase

66,366

23.2942  USD

USD 0.01 common

Sale

2

23.2300  USD

USD 0.01 common

Sale

3

23.2433  USD

USD 0.01 common

Sale

64

23.4900  USD

USD 0.01 common

Sale

90

23.2500  USD

USD 0.01 common

Sale

100

23.4950  USD

USD 0.01 common

Sale

100

23.3700  USD

USD 0.01 common

Sale

100

23.2650  USD

USD 0.01 common

Sale

100

23.2850  USD

USD 0.01 common

Sale

100

23.2150  USD

USD 0.01 common

Sale

102

23.2550  USD

USD 0.01 common

Sale

200

23.2900  USD

USD 0.01 common

Sale

200

23.2950  USD

USD 0.01 common

Sale

212

23.2000  USD

USD 0.01 common

Sale

263

23.2800  USD

USD 0.01 common

Sale

408

23.2843  USD

USD 0.01 common

Sale

420

23.2448  USD

USD 0.01 common

Sale

600

23.2600  USD

USD 0.01 common

Sale

600

23.2050  USD

USD 0.01 common

Sale

684

23.3030  USD

USD 0.01 common

Sale

838

23.3126  USD

USD 0.01 common

Sale

900

23.2883  USD

USD 0.01 common

Sale

1,200

23.2083  USD

USD 0.01 common

Sale

1,391

23.2748  USD

USD 0.01 common

Sale

1,426

23.2100  USD

USD 0.01 common

Sale

2,108

23.3343  USD

USD 0.01 common

Sale

2,307

23.3426  USD

USD 0.01 common

Sale

2,762

23.2071  USD

USD 0.01 common

Sale

3,939

23.2751  USD

USD 0.01 common

Sale

4,439

23.3464  USD

USD 0.01 common

Sale

4,920

23.3522  USD

USD 0.01 common

Sale

5,631

23.2777  USD

USD 0.01 common

Sale

7,349

23.3023  USD

USD 0.01 common

Sale

10,583

23.2896  USD

USD 0.01 common

Sale

11,408

23.2956  USD

USD 0.01 common

Sale

15,832

23.2717  USD

USD 0.01 common

Sale

23,625

23.2809  USD

USD 0.01 common

Sale

30,408

23.3367  USD

USD 0.01 common

Sale

33,107

23.2906  USD

USD 0.01 common

Sale

34,933

23.2200  USD

USD 0.01 common

Sale

44,844

23.2823  USD









(b)

Cash-settled derivative transactions


Class of

Product

Nature of dealing

Number of

Price per

relevant

description


reference

unit

security



securities















(c)

Stock-settled derivative transactions (including options)


(i)

Writing, selling, purchasing or varying


Class

Product

Writing,

Number

Exercise

Type

Expiry

Option

of

description

purchasing,

of

price


date

money

relevant


selling,

securities

per unit



paid/

security


varying etc

to which




received




option




per unit




relates





















(ii)

Exercising







Class of relevant

Product description

Exercising/ exercised against

Number of

Exercise price per

security



securities

unit














(d)

Other dealings (including subscribing for new securities)


Class of relevant

Nature of Dealings

Details

Price per unit (if

security



applicable)





4.

OTHER INFORMATION

(a)

Indemnity and other dealings arrangements


Details of any indemnity or option arrangement, or any agreement or understanding,



formal or informal, relating to relevant securities which may be an inducement to deal



or refrain from dealing entered into by the exempt principal trader making the disclosure and any party


to the offer or any person acting in concert with a party to the offer:




NONE

(b)

Agreements, arrangements or understandings relating to options or derivatives


Details of any agreement, arrangement or understanding, formal or informal, between



the person making the disclosure and any other person relating to:



(i)  the voting rights of any relevant securities under any option; or




(ii) the voting rights of future acquisition or disposal of any relevant securities to which



any derivative is referenced:







NONE

(c)

Attachments







Is a Supplemental Form 8 (Open Positions) attached?

YES

Date of disclosure:

24 Aug 2022

Contact name:

Large Holdings Regulatory Operations

Telephone number:

020 3134 7213

























DETAILS OF OPEN OPTION AND DERIVATIVE POSITIONS, AGREEMENTS TO

PURCHASE OR SELL ETC.

Note 5(i) on Rule 8 of the Takeover Code (the "Code")

1.

KEY INFORMATION

Identity of the person whose positions/dealings

Barclays PLC.

are being disclosed:

Name of offeror/offeree in relation to whose

NORTONLIFELOCK INC

relevant securities this from relates:









2.

OPTIONS AND DERIVATIVES

Class of relevant security

Product description

Writing, purchasing, selling, varying etc

Number of securities to which option relates

Exercise price per unit

Type

Expiry date

USD 0.01 common

Call Options

Written

-17,100

27.0000

American

16 Sep 2022

USD 0.01 common

Put Options

Written

17,100

25.0000

American

16 Sep 2022









3.

AGREEMENTS TO PURCHASE OR SELL ETC.

Full details should be given so that the nature of the interest or position can be fully understood:

























 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RETBKQBPKBKDPFB

Companies

Barclays (BARC)
UK 100

Latest directors dealings